Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Should You Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped down before the market opened on Friday . The stock had previously closed at $9.37, but opened at $9.00. Curaleaf shares last traded at $9.20, with a volume of 9,220 shares.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Three research analysts have rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Strong Buy”.

Curaleaf Price Performance

The company has a 50-day moving average of $7.25 and a two-hundred day moving average of $7.63. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.56 and a quick ratio of 0.74. The stock has a market capitalization of $2.16 billion, a PE ratio of -23.72 and a beta of 1.51.

Curaleaf (OTCMKTS:CURLF) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of ($0.24) by $0.51. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%.The company had revenue of $324.23 million during the quarter, compared to analysts’ expectations of $316.62 million. Sell-side analysts predict that Curaleaf Holdings, Inc. will post -0.31 EPS for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.